
Becton, Dickinson and Company (BDX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
187.62 - Open
185.42 - Bid 184.12 x 20000
- Ask 184.89 x 10000
- Day's Range
184.05 - 187.13 - 52 Week Range
127.59 - 193.07 - Volume
1,439,059 - Avg. Volume
2,120,672 - Market Cap (intraday)
50.321B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
31.96 - EPS (TTM)
5.78 - Earnings Date (est.) Nov 5, 2026
- Forward Dividend & Yield 4.20 (2.24%)
- Ex-Dividend Date Sep 9, 2026
- 1y Target Est
195.67
Recent News
View MorePerformance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
51.08B
-
Enterprise Value
67.18B
-
Trailing P/E
32.44
-
Forward P/E
14.10
-
PEG Ratio (5yr expected)
1.11
-
Price/Sales (ttm)
2.36
-
Price/Book (mrq)
2.09
-
Enterprise Value/Revenue
2.99
-
Enterprise Value/EBITDA
13.65
Financial Highlights
Profitability and Income Statement
-
Profit Margin
4.19%
-
Return on Assets (ttm)
4.34%
-
Return on Equity (ttm)
6.61%
-
Revenue (ttm)
22.48B
-
Net Income Avi to Common (ttm)
1.65B
-
Diluted EPS (ttm)
5.78
Balance Sheet and Cash Flow
-
Total Cash (mrq)
709M
-
Total Debt/Equity (mrq)
68.84%
-
Levered Free Cash Flow (ttm)
4.48B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports
View More-
Becton Dickinson Earnings: Course Correction On Track; Guidance Upgrade; Shares Cheap
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
RatingPrice Target -
BD Begins Its Post-Life Sciences Era
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
RatingPrice Target -
Raising EPS estimates
Headquartered in Franklin Lakes, NJ, BD manufacturers and sells a broad range of medical equipment and supplies. It operates through four business segments: Medical Essentials, Connected Care, BioPharma Systems, and Interventional.
RatingPrice Target -
Major stock indices have been dancing around a flat line Friday morning,
Major stock indices have been dancing around a flat line Friday morning, although as noon approaches there appears to be a bit of move higher underway. Still, a quiet session may not be the worst thing to end a week that has had a downward bias. Week to date, the S&P 500 is off almost 2%, the Nasdaq is off almost 5%, the Dow Jones Industrial Average is essentially flat. Factors in play for investors include the ongoing struggle to decide how to next play the technology/AI trade for stocks like Micron (up 306% year to date) and Nvidia (up a mere 3%). And then there is the issue of interest rates, as January assumptions that one or two rate cuts were likely in 2026 have turned to a belief that no rate cuts are likely and, indeed, a rate hike may be in order. Next up is the war in Iran. Will it ever really 'end,' or will it have a tail that wags forever in the form of a volatile and unpredictable Strait of Hormuz? Those are all tough issues to ponder - and, before you know it, second-quarter earnings reports will be added to the daily newsflow. Here we are argue any even reasonably positive distraction from the above events would likely be good. In other areas of interest, Bitcoin is currently around $60,000 (down 31% YTD), crude oil is at $69 a barrel (up 19% YTD), the 10-year Treasury yield is at 4.37%, and the VIX Volatility Index is t a relatively calm 19.








